Willem A. Nolen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Willem A. Nolen has a total of 230 co-authors. Here are the top co-authors by number of shared publications:
- Ralph W. Kupka
Department of Psychiatry, Amsterdam Public Mental Health Research Institute Amsterdam University Medical Center, Vrije Universiteit Amsterdam the Netherlands
7 shared publications - Brenda W. J. H. Penninx
Amsterdam UMC
6 shared publications - Eline J. Regeer
Altrecht Institute for Mental Health Care, Utrecht, the Netherlands
5 shared publications - Heinz Grunze
Psychiatrie Schwäbisch Hall, Schwäbisch Hall, Germany
3 shared publications - Hemmo A. Drexhage
Dept of Immunology, Erasmus Medical Center, Rotterdam, The Netherlands
3 shared publications - Joannes W. Renes
Altrecht Institute for Mental Health Care, Utrecht, the Netherlands
3 shared publications
Latest Publications
- 8 October 2024
- Published by Springer Nature in Social Psychiatry and Psychiatric Epidemiology
- Vol. 60 (6) , 1489-1497
Shared decision-making in the treatment of bipolar disorder: findings from a nationwide naturalistic cohort study in everyday clinical practice
Background Shared decision-making (SDM) is of increasing importance in mental health care, however, large studies on the effects of SDM in bipolar disorder (BD) are scarce. Aim To gain insight into the relationships between SDM, guideline concordance of treatments in everyday practice, satisfaction with care, and medication adherence in BD. Method In a nationwide observational study on the treatment of BD, patients were asked questions about their involvement in treatment. These questions were clustered according to the three-talk model (TTM) for SDM, which involves team talk, option talk, and decision talk. A composite concordance score for multimodal treatments was made, and satisfaction with care (score 1 to 10) and medication adherence (DAI-10) were measured. Results 839 patients with BD from various outpatient treatment centers were included. Patients were highly involved in decision-making. In multiple regression, team talk was significantly positively associated with guideline concordance (b = 5.10, p = .045), and decision talk was positively associated with satisfaction with care (b = 0.82, p < .001) and medication adherence (b = 1.18, p = .003). Conclusion Positive associations were found between SDM, guideline concordance, satisfaction with care, and medication adherence, suggesting that investing in these steps of the decision-making process together with patients and their significant others, will help to improve quality of care.
- 8 October 2024
- Published by Springer Nature in Social Psychiatry and Psychiatric Epidemiology
- Vol. 60 (6) , 1489-1497
Shared decision-making in the treatment of bipolar disorder: findings from a nationwide naturalistic cohort study in everyday clinical practice
Background Shared decision-making (SDM) is of increasing importance in mental health care, however, large studies on the effects of SDM in bipolar disorder (BD) are scarce. Aim To gain insight into the relationships between SDM, guideline concordance of treatments in everyday practice, satisfaction with care, and medication adherence in BD. Method In a nationwide observational study on the treatment of BD, patients were asked questions about their involvement in treatment. These questions were clustered according to the three-talk model (TTM) for SDM, which involves team talk, option talk, and decision talk. A composite concordance score for multimodal treatments was made, and satisfaction with care (score 1 to 10) and medication adherence (DAI-10) were measured. Results 839 patients with BD from various outpatient treatment centers were included. Patients were highly involved in decision-making. In multiple regression, team talk was significantly positively associated with guideline concordance (b = 5.10, p = .045), and decision talk was positively associated with satisfaction with care (b = 0.82, p < .001) and medication adherence (b = 1.18, p = .003). Conclusion Positive associations were found between SDM, guideline concordance, satisfaction with care, and medication adherence, suggesting that investing in these steps of the decision-making process together with patients and their significant others, will help to improve quality of care.
- Open Access
- 14 November 2022
- Published by Springer Nature in International Journal of Bipolar Disorders
- Vol. 10 (1) , 1
Correction: New vision on the mental problems of Vincent van Gogh; results from a bottom-up approach using (semi-)structured diagnostic interviews
- 14 November 2022
- Published by Springer Nature in International Journal of Bipolar Disorders
- Vol. 10 (1) , 1
Open AccessCorrection: New vision on the mental problems of Vincent van Gogh; results from a bottom-up approach using (semi-)structured diagnostic interviews
- Open Access
- 5 August 2021
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 16, 100319
Association of the neutrophil to lymphocyte ratio and white blood cell count with response to pharmacotherapy in unipolar psychotic depression: An exploratory analysis
- 5 August 2021
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 16, 100319
Open AccessAssociation of the neutrophil to lymphocyte ratio and white blood cell count with response to pharmacotherapy in unipolar psychotic depression: An exploratory analysis
- Open Access
- 1 August 2021
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 130, 105278
Plasma androgens and the presence and course of depression in a large cohort of men
- 1 August 2021
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 130, 105278
Open AccessPlasma androgens and the presence and course of depression in a large cohort of men
- Open Access
- 1 March 2021
- Published by Elsevier in Journal of Affective Disorders
- Vol. 283, 395-401
Guideline concordance and outcome in long-term naturalistic treatment of bipolar disorder - a one-year longitudinal study using latent change models
- 1 March 2021
- Published by Elsevier in Journal of Affective Disorders
- Vol. 283, 395-401
Open AccessGuideline concordance and outcome in long-term naturalistic treatment of bipolar disorder - a one-year longitudinal study using latent change models
- Top Cited PapersOpen Access
- 2 November 2020
- Published by Springer Nature in International Journal of Bipolar Disorders
- Vol. 8 (1) , 1-9
New vision on the mental problems of Vincent van Gogh; results from a bottom-up approach using (semi-)structured diagnostic interviews
Background: On July 29, 1890 at the age of 37 years, the Dutch painter Vincent van Gogh died from the consequences of a suicide attempt with a gun 2 days earlier. Since then many medical and psychological theories were suggested about what had happened to Van Gogh.Aim: To present an overview of the history of the mental problems of Van Gogh and the most likely diagnoses.Method: (Semi-)structured diagnostic interviews were applied to three art historians who are very familiar with Van Gogh from his correspondence and other sources as well as a neuropsychiatric examination to evaluate whether the symptoms might be explained by a medical condition.Results: Several previously suggested diagnoses could be excluded as being highly unlikely, while other diagnoses could be classified as more of less likely.Conclusion: Most likely Van Gogh suffered from comorbid illnesses. Since young adulthood, he likely developed a (probably bipolar) mood disorder in combination with (traits of) a borderline personality disorder as underlying vulnerability. This likely worsened through an alcohol use disorder combined with malnutrition, which then led, in combination with rising psychosocial tensions, to a crisis in which he cut off his ear. Thereafter, he likely developed two deliriums probably related to alcohol withdrawal, followed by a worsening with severe depressive episodes (of which at least one with psychotic features) from which he did not fully recover, finally leading to his suicide. As additional comorbidity, focal (temporal lobe) epilepsy cannot be excluded.
- 2 November 2020
- Published by Springer Nature in International Journal of Bipolar Disorders
- Vol. 8 (1) , 1-9
Top Cited PapersOpen AccessNew vision on the mental problems of Vincent van Gogh; results from a bottom-up approach using (semi-)structured diagnostic interviews
Background: On July 29, 1890 at the age of 37 years, the Dutch painter Vincent van Gogh died from the consequences of a suicide attempt with a gun 2 days earlier. Since then many medical and psychological theories were suggested about what had happened to Van Gogh.Aim: To present an overview of the history of the mental problems of Van Gogh and the most likely diagnoses.Method: (Semi-)structured diagnostic interviews were applied to three art historians who are very familiar with Van Gogh from his correspondence and other sources as well as a neuropsychiatric examination to evaluate whether the symptoms might be explained by a medical condition.Results: Several previously suggested diagnoses could be excluded as being highly unlikely, while other diagnoses could be classified as more of less likely.Conclusion: Most likely Van Gogh suffered from comorbid illnesses. Since young adulthood, he likely developed a (probably bipolar) mood disorder in combination with (traits of) a borderline personality disorder as underlying vulnerability. This likely worsened through an alcohol use disorder combined with malnutrition, which then led, in combination with rising psychosocial tensions, to a crisis in which he cut off his ear. Thereafter, he likely developed two deliriums probably related to alcohol withdrawal, followed by a worsening with severe depressive episodes (of which at least one with psychotic features) from which he did not fully recover, finally leading to his suicide. As additional comorbidity, focal (temporal lobe) epilepsy cannot be excluded.
- Open Access
- 27 September 2020
- Published by Wiley in Bipolar Disorders
- Vol. 23 (1) , 92
Lithium: The best current treatment for the well‐informed bipolar patient
- 27 September 2020
- Published by Wiley in Bipolar Disorders
- Vol. 23 (1) , 92
Open AccessLithium: The best current treatment for the well‐informed bipolar patient
- 11 July 2020
- Published by Wiley in Bipolar Disorders
- Vol. 23 (1) , 86-87
A skewed perspective – A reply to Kovvuru et al
Click on the article title to read more.
- 11 July 2020
- Published by Wiley in Bipolar Disorders
- Vol. 23 (1) , 86-87
A skewed perspective – A reply to Kovvuru et al
Click on the article title to read more.
- Open Access
- 11 June 2020
- Published by Springer Nature in Research Square
New Vision on the Mental Problems of Vincent Van Gogh; Results From a Bottom-up Approach Using (Semi-)structured Diagnostic Interviews
Background: On July 29, 1890 at the age of 37 years, the Dutch painter Vincent van Gogh died from the consequences of a suicide attempt with a gun two days earlier. Since then many medical and psychological theories were suggested about what had happened to Van Gogh.Aim: To present an overview of the history of the mental problems of Van Gogh and the most likely diagnoses.Method: (Semi-)structured diagnostic interviews were applied to three art historians who are very familiar with Van Gogh from his correspondence and other sources and as well as a neuropsychiatric examination to evaluate whether the symptoms might be explained by a medical conditionResults: Several previously suggested diagnoses could be excluded as being highly unlikely, while other diagnoses could be classified as more of less likely. Conclusion: Most likely Van Gogh suffered from comorbid illnesses. Since young adulthood, he likely developed a (probably bipolar) mood disorder in combination with (traits of) a borderline personality disorder as underlying vulnerability. This likely worsened through an alcohol use disorder combined with malnutrition, which then led, in combination with rising psychosocial tensions, to a crisis in which he cut off his ear. Thereafter, he likely developed two deliriums probably related to alcohol withdrawal, followed by a worsening with severe depressive episodes (of which at least one with psychotic features) from which he did not fully recover, finally leading to his suicide.As additional comorbidity,focal (temporal lobe)epilepsy cannot be excluded.
- 11 June 2020
- Published by Springer Nature in Research Square
Open AccessNew Vision on the Mental Problems of Vincent Van Gogh; Results From a Bottom-up Approach Using (Semi-)structured Diagnostic Interviews
Background: On July 29, 1890 at the age of 37 years, the Dutch painter Vincent van Gogh died from the consequences of a suicide attempt with a gun two days earlier. Since then many medical and psychological theories were suggested about what had happened to Van Gogh.Aim: To present an overview of the history of the mental problems of Van Gogh and the most likely diagnoses.Method: (Semi-)structured diagnostic interviews were applied to three art historians who are very familiar with Van Gogh from his correspondence and other sources and as well as a neuropsychiatric examination to evaluate whether the symptoms might be explained by a medical conditionResults: Several previously suggested diagnoses could be excluded as being highly unlikely, while other diagnoses could be classified as more of less likely. Conclusion: Most likely Van Gogh suffered from comorbid illnesses. Since young adulthood, he likely developed a (probably bipolar) mood disorder in combination with (traits of) a borderline personality disorder as underlying vulnerability. This likely worsened through an alcohol use disorder combined with malnutrition, which then led, in combination with rising psychosocial tensions, to a crisis in which he cut off his ear. Thereafter, he likely developed two deliriums probably related to alcohol withdrawal, followed by a worsening with severe depressive episodes (of which at least one with psychotic features) from which he did not fully recover, finally leading to his suicide.As additional comorbidity,focal (temporal lobe)epilepsy cannot be excluded.
- Open Access
- 21 May 2019
- Published by Wiley in Bipolar Disorders
- Vol. 21 (5) , 394-409
What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium
Aims: To systematically review the existing trials on optimal serum levels for lithium for maintenance treatment of bipolar disorder and to develop clinical recommendations.Methods: Systematic literature search. Discussion of major characteristics, limitations, methodological quality, and results of selected trials. Delphi survey consisting of clinical questions and corresponding statements. For statements endorsed by at least 80% of the members, consensus was considered as having been achieved.Results: With strict inclusion criteria no studies could be selected, making it difficult to formulate evidence‐based recommendations. After loosening the inclusion criteria 7 trials were selected addressing our aims at least to some extent. Four of these studies suggest better efficacy being associated with lithium serum levels in a range above a lower threshold around 0.45/0.60 and up to 0.80/1.00 mmol/L. These findings support the outcome of the Delphi survey.Conclusions: For adults with bipolar disorder there was consensus that the standard lithium serum level should be 0.60‐0.80 mmol/L with the option to reduce it to 0.40‐0.60 mmol/L in case of good response but poor tolerance or to increase it to 0.80‐1.00 mmol/L in case of insufficient response and good tolerance. For children and adolescents there was no consensus, but the majority of the members endorsed the same recommendation. For the elderly there was also no consensus, but the majority of the members endorsed a more conservative approach: usually 0.40‐0.60 mmol/L, with the option to go to maximally 0.70 or 0.80 mmol/L at ages 65‐79 years, and to maximally 0.70 mmol/L over age 80 years.
- 21 May 2019
- Published by Wiley in Bipolar Disorders
- Vol. 21 (5) , 394-409
Open AccessWhat is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium
Aims: To systematically review the existing trials on optimal serum levels for lithium for maintenance treatment of bipolar disorder and to develop clinical recommendations.Methods: Systematic literature search. Discussion of major characteristics, limitations, methodological quality, and results of selected trials. Delphi survey consisting of clinical questions and corresponding statements. For statements endorsed by at least 80% of the members, consensus was considered as having been achieved.Results: With strict inclusion criteria no studies could be selected, making it difficult to formulate evidence‐based recommendations. After loosening the inclusion criteria 7 trials were selected addressing our aims at least to some extent. Four of these studies suggest better efficacy being associated with lithium serum levels in a range above a lower threshold around 0.45/0.60 and up to 0.80/1.00 mmol/L. These findings support the outcome of the Delphi survey.Conclusions: For adults with bipolar disorder there was consensus that the standard lithium serum level should be 0.60‐0.80 mmol/L with the option to reduce it to 0.40‐0.60 mmol/L in case of good response but poor tolerance or to increase it to 0.80‐1.00 mmol/L in case of insufficient response and good tolerance. For children and adolescents there was no consensus, but the majority of the members endorsed the same recommendation. For the elderly there was also no consensus, but the majority of the members endorsed a more conservative approach: usually 0.40‐0.60 mmol/L, with the option to go to maximally 0.70 or 0.80 mmol/L at ages 65‐79 years, and to maximally 0.70 mmol/L over age 80 years.